Drug Hunter Interview
January 26, 2023
Drug Hunter Flash Talk with Prof. Hande Ozdinler, Ph.D. and Prof. Richard B. Silverman, Ph.D.
Read More
A Long Swim
January 26, 2023
A Long Swim co-founder and executive director Doug McConnell sits down with Dr. Hande Ozdinler, A Long Swim Director of Science and Associate Professor of Neurology at Northwestern University, and...
Read More
Akava receives Orphan Drug Designation status for AKV9
July 6, 2022
Akava Therapeutics, Inc. announces that on July 6, 2022, orphan drug designation (ODD) status was received for AKV9 for the treatment of amyotrophic lateral sclerosis (ALS) from the U.S. Food...
Read More
This time around, Lyrica’s inventor is developing his Northwestern discoveries at his own biotech
May 26, 2022
Richard Silverman was left in the dark for the last five years of clinical development of the drug he discovered. The Northwestern University professor found out about the first approval...
Read More
NU‑9 improves health of hSOD1G93A mouse upper motor neurons in vitro, especially in combination with riluzole or edaravone
March 30, 2022
A paper has recently been published demonstrating that AKV9 improves the health of mutant SOD1 mouse upper motor neurons in vitro much better than the FDA-approved ALS drugs riluzole and edaravone, and the combination of AKV9 with either of those drugs provides an additive effect.
Read More